Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.6%

1 terminated out of 18 trials

Success Rate

92.3%

+5.8% vs benchmark

Late-Stage Pipeline

22%

4 trials in Phase 3/4

Results Transparency

17%

2 of 12 completed with results

Key Signals

2 with results92% success

Data Visualizations

Phase Distribution

10Total
P 1 (3)
P 2 (3)
P 3 (1)
P 4 (3)

Trial Status

Completed12
Recruiting2
Withdrawn2
Terminated1
Not Yet Recruiting1

Trial Success Rate

92.3%

Benchmark: 86.5%

Based on 12 completed trials

Clinical Trials (18)

Showing 18 of 18 trials
NCT02677961Recruiting

An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry

NCT06335251RecruitingPrimary

Radiotherapy Treatments for Neoplasms of the Limbs

NCT06979115Not Yet RecruitingPrimary

Investigation Into the Safety and Efficacy of ICG-Labeled Fluorescence Imaging Technology in Guiding the Resection of Bone and Soft Tissue Tumors

NCT00095017Phase 2WithdrawnPrimary

Safety and Efficacy of an Investigational Drug Versus Placebo in the Treatment of Cancer Pain (0663-083)

NCT01479283Phase 3Completed

Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY)

NCT00381095Phase 4TerminatedPrimary

A Study To Evaluate Pregabalin In The Treatment Of Moderate To Severe Chronic Bone Pain Related To Metastatic Cancer

NCT04300179Completed

Ewing Sarcoma Family of Tumors (ESFT): A 15-year Experience From a Tertiary Care Cancer Center in Upper Egypt

NCT02557243Completed

Malignant Pediatric Soft Tissue & Bone Tumors of the Extremities: A Retrospective Study

NCT02274623Phase 1Completed

Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic Acid

NCT02107664Completed

The Palliative Radiotherapy And Inflammation Study - PRAIS

NCT03839095CompletedPrimary

Localized Osteosarcoma in Upper Egypt: A Clinical Prediction Model

NCT00211211Phase 4Completed

FREE Study - Fracture Reduction Evaluation

NCT02303366Phase 1Completed

Pilot Study of Stereotactic Ablation for Oligometastatic Breast Neoplasia in Combination With the Anti-PD-1 Antibody MK-3475

NCT00434447Phase 4CompletedPrimary

Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases

NCT00558272Phase 2Completed

Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease

NCT00851162Phase 2WithdrawnPrimary

Using Mesenchymal Stem Cells to Fill Bone Void Defects in Patients With Benign Bone Lesions

NCT00909142CompletedPrimary

Bonefos and the Consumption of Analgesics

NCT00168129Phase 1CompletedPrimary

Helical Tomotherapy as a Radiotherapy Technique for Treating Bone Metastases

Showing all 18 trials

Research Network

Activity Timeline